A case of inclusion body myositis responsive to prednisolone therapy
- 6 December 2008
- journal article
- case report
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 28 (1), 21-22
- https://doi.org/10.1007/s10067-008-1047-1
Abstract
Inclusion body myositis, although rare, is the commonest cause of myopathy in patients aged over 50 years. The suggested pathogenesis remains uncertain and its prognosis remains poor. There have been select case reports of its association with an inflammatory etiology and it is postulated that this group of patients respond better to immunosuppressive therapy. We therefore report a rare case of inclusion body myositis that responded well to immunosuppressive therapy. We also report the possibility of its association with infliximab therapy.This publication has 9 references indexed in Scilit:
- Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBMNeurology, 2008
- Inclusion-body myositisNeurology, 2006
- Injection of Botulinum Toxin a to Upper Esophageal Sphincter for Oropharyngeal Dysphagia in Two Patients with Inclusion Body MyositisCanadian Journal of Gastroenterology, 2004
- Inclusion body myositis in connective tissue disorders: case report and review of the literatureClinical Rheumatology, 2003
- Polymyositis associated with infliximab treatment for rheumatoid arthritisRheumatology, 2003
- Epidemiology of inclusion body myositis in the Netherlands: A nationwide studyNeurology, 2000
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995
- Polymyositis, Dermatomyositis, and Inclusion-Body MyositisThe New England Journal of Medicine, 1991
- INCLUSION BODY MYOSITISBrain, 1989